Skip to main content
Skip to main content Skip to site footer
hamburger menu hamburger menu
  • Who We Are
  • What We Do
  • Areas of R&D
  • Projects
    • Matrix
    • Project Engage
    • Project Uchoose
    • Project Horizon
    • Past Projects
      • NIX HIV
  • Publications
    • Adherence Monitoring and Support
    • Biomarkers
    • HIV/STI Susceptibility
    • Product Development
    • Clinical Trials
    • HIV Prevention Technologies
    • Novel Contraceptive Technologies

Adherence Monitoring and Support

Quantification of Antiretroviral Drug Emtricitabine in Human Plasma by Surface Enhanced Raman Spectroscopy. Butler MR, Jacot TA, Dutta SM, Doncel GF, Cooper JB. 2024 Nov 25.

Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence. Zissette S, Tolley EE, Martinez A, Hanif H, Gill K, Mugo N, Myers L, Casmir E, Duyver M, Ngure K, Doncel GF. 2021 May 27.

Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies. Jacot TA, Clark MR, Adedipe OE, Godbout S, Peele AG, Ju S, Schwartz JL, Thurman AR, Doncel GF. 2018 Nov 7.

Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques. Adedipe OE, Jacot TA, Thurman AR, Doncel GF, Clark MR. 2018 May 25.

Development of a composite measure of product adherence, protocol compliance, and semen exposure using DNA and protein biomarkers for topical HIV prevention studies. Jacot TA, Nelson A, Thurman A, Kashuba AD, Archer DF, Doncel GF. 2014 Dec 9.

Conrad logo
Eastern Virginia Medical School horizontal RGB fullcolor PNG
  • Areas of R&D
  • Projects
  • Publications
  • What We Do
  • Who We Are

Email: CONRADInnovations@odu.edu

Phone: 757.446.8908

Copyright © 2025 CONRAD. All Rights Reserved.

Privacy Policy